Page last updated: 2024-10-30

losartan and Actinic Reticuloid Syndrome

losartan has been researched along with Actinic Reticuloid Syndrome in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakao, S1
Hatahira, H1
Sasaoka, S1
Hasegawa, S1
Motooka, Y1
Ueda, N1
Abe, J1
Fukuda, A1
Naganuma, M1
Kanoh, H1
Seishima, M1
Ishiguro, M1
Kinosada, Y1
Nakamura, M1

Other Studies

1 other study available for losartan and Actinic Reticuloid Syndrome

ArticleYear
Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database.
    Biological & pharmaceutical bulletin, 2017, Volume: 40, Issue:12

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Angiotensin II

2017